← Open Payments lookup

STEPHEN HIX: Open Payments

NPI 1477224392 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,622 in 71 payments from 23 companies in 2025. Trend: 2023 $1,008 · 2024 $1,313 · 2025 $1,622

Food & beverage: $1,622
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.10$234
Madrigal Pharmaceuticals6$204
SHIELD THERAPEUTICS INC3$159
AstraZeneca Pharmaceuticals LP8$148
Merck Sharp & Dohme LLC4$92
Aimmune Therapeutics, Inc.5$87
Janssen Biotech, Inc.5$85
GENZYME CORPORATION4$83
Novartis Pharmaceuticals Corporation3$71
Daiichi Sankyo Inc.3$69

Products named: REZDIFFRA, ACCRUFER, ENTYVIO, LYNPARZA, KEYTRUDA, TREMFYA, DUPIXENT, EOHILIA.

Industry payments across OK — which companies pay providers there.